In 2022, Dr. Maura Abbott, Associate Professor of Nursing at the Columbia University School of Nursing, served as faculty for i3 Health’s CME/NCPD approved activity, New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia. Now, in this follow-up interview with Oncology Data Advisor, Dr. Abbott reinforces the importance of educating patients who are at risk for chemotherapy-induced neutropenia and shares some of the therapeutic developments in both prevention and management that are coming down the pipeline in the near future.

Listen to the free CME/NCPD activity, New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia, after the interview and click here to claim credit: i3health.com/44-policies/503-i3health-com-cin